ClassID:

94273

C07D215/24 - CPC Classification

Classification description:

Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Oxygen atoms attached in position 8

Sub-classes:
Recent Application in this class:
#1
20250361210
2025-11-27

3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND

#2
20210380551
2021-12-09

α,β-unsaturated amide compound

#3
20210262105
2021-08-26

Acidic aqueous composition for electrolytic copper plating

#4
20190241554
2019-08-08

1,3 di-substituted cyclobutane or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitors

#5
20190106408
2019-04-11

Method for preparing the anhydrous crystalline form of isoniazid-derived hydrazone, thus produced crystalline polymorph of the anyhydrous form, use thereof for the treatment of alzheimer's disease, parkinsonism and other neurodegenerative disorders, and pharamceutical composition

#6
20190010136
2019-01-10

α,β-unsaturated amide compound

#7
20180148437
2018-05-31

Novel Ezrin Inhibitors and Methods of Making and Using

#8
20180141911
2018-05-24

Quinoline Derivatives for Diagnosis and Treatment of Alzheimer's Disease

#9
20170158665
2017-06-08

Method for preparing the anhydrous crystalline form of isoniazid-derived hydrazone, thus produced cristalline polymorph of the anhydrous form, use thereof for the treatment of Alzheimer's disease, parkinsonism and other neurodegenerative disorders, and pharmaceutical composition

#10
20160304461
2016-10-20

QUINOLONE COMPOUND AND PHARMACEUTICAL COMPOSITION

#11
20160257651
2016-09-08

NOVEL COMPOUND WITH ANTIBACTERIAL ACTIVITY

#12
20160131648
2016-05-12

Alkyl quinolones as biomarkers of pseudomonas aeruginosa infection and uses thereof

#13
20160031819
2016-02-04

Base addition salts of nitroxoline and uses thereof

#14
20160002168
2016-01-07

Use of quinoline derivatives for improving plant yield

#15
20150364703
2015-12-17

Organic light-emitting device and display apparatus

#16
20150094334
2015-04-02

8-hydroxy quinoline derivatives

#17
20150080430
2015-03-19

Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders

#18
20150025108
2015-01-22

8-hydroxy quinoline derivatives

#19
20140323520
2014-10-30

Compositions and methods for increasing proliferation of adult salivary stem cells

#20
20140194463
2014-07-10

COMPOSITIONS FOR TREATMENT OF CANCER

#21
20140194429
2014-07-10

COMPOSITIONS FOR TREATMENT OF CANCER

#22
20140135325
2014-05-15

Ezrin inhibitors and methods of making and using

#23
20140121238
2014-05-01

Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents

#24
20130203689
2013-08-08

Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof

#25
20120316168
2012-12-13

Quinolone compound and pharmaceutical composition

#26
20120071654
2012-03-22

ARYL ANILINE DERIVATIVES AS BETA2 ADRENERGIC RECEPTOR AGONISTS

#27
20120041197
2012-02-16

Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these

#28
20110193064
2011-08-11

Diaminopyrene derivative and organic EL device using the same

#29
20110144155
2011-06-16

8-HYDROXYQUINOLINE DERIVATIVES FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES

#30
20110059967
2011-03-10

Therapeutic compounds

#31
20110046374
2011-02-24

Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these

#32
20100279873
2010-11-04

Halogen alkoxy spirocyclic tetramic and tetronic acid derivatives

#33
20100130546
2010-05-27

Quinolone compound and pharmaceutical composition

#34
20100087410
2010-04-08

Aryl aniline derivatives as βadrenergic receptor agonists

#35
20100063282
2010-03-11

Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions, and Uses Thereof

#36
20100048447
2010-02-25

Bis(hydroxyquinoline) metal complexes as bleach catalysts

#37
20090200925
2009-08-13

ORGANIC ELECTROLUMINESCENT ELEMENT, LIGHTING DEVICE AND DISPLAY DEVICE

#38
20080317662
2008-12-25

Molten Salts, Method of Their Production and Process for Generating Hydrogen Peroxide

#39
20080284322
2008-11-20

Nitrogenous heterocyclic derivative and organic electroluminescence device making use of the same

#40
20080227979
2008-09-18

Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these

#41
20080161353
2008-07-03

8-hydroxy quinoline derivatives

#42
20060089380
2006-04-27

8-hydroxy quinoline derivatives

#43
20050165052
2005-07-28

Substituted quinolines for the treatment of protozoa and retrovirus co-infections

#44
20050159448
2005-07-21

Aryl aniline derivatives as βadrenergic receptor agonists